6:49 PM
 | 
Mar 07, 2008
 |  BC Extra  |  Company News

Ista off after Xibrom QD update

Ista (NASDAQ:ISTA) was off $1.24 (31%) to $2.71 on Friday after it withdrew the clinical section of its NDA for once-daily Xibrom QD to treat inflammation, pain and photophobia following cataract surgery. The move followed an FDA request for additional...

Read the full 187 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >